Top Markets
Coin of the day
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Classement en actions #20782
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Prix de l'action
$0.8657
Dernière synchronisation: 2022-01-26
Capitalisation boursière
$122.22M
Changement (1 jour)
-0.88%
Changement (1 an)
0.00%
Pays
US
Échange ZIOPHARM Oncology, Inc. (ZIOP)

Catégorie

Le prix ZIOP avec la capitalisation boursière de B
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
$0.8657
Capitalisation boursière de ZIOPHARM Oncology, Inc.(ZIOP)
Capitalisation boursière: $122.22M
En August 2026, ZIOPHARM Oncology, Inc. a une capitalisation boursière de $122.22M. Cela fait de ZIOPHARM Oncology, Inc. la 20782nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ZIOPHARM Oncology, Inc. du 2006 au 2026
ZIOP par rapport au top 5 des plus populaires stocks
Prix pour ZIOP L’actif B La capitalisation boursière de B Résultats
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$36,911.68 $122.22M
$5.211T +4,263,695.77%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$32,204.21 $122.22M
$4.547T +3,719,919.96%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$29,482.46 $122.22M
$4.162T +3,405,521.01%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$25,447.43 $122.22M
$3.593T +2,939,420.54%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$19,781.55 $122.22M
$2.793T +2,284,935.02%